CHINA LEX PHARMA NEWSLETTER
Vol. 1, No. 22 - October 19, 2000
Lehman, Lee & Xu
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
(formerly known as the L&A Law Firm)
mail@chinalaw.cc
Contact Our Other Offices:
shanghai@chinalaw.cc - shenyang@chinalaw.cc - tianjin@chinalaw.cc - guangzhou@chinalaw.cc - dalian@chinalaw.cc
Pharma Regulations to be Drafted against Redundant Drug Products
Mr. Zheng Xiaoyu, head of China's State Drug Administration, said recently that they would draft pharma regulations with an intention to eliminate redundant drug products.
Duplicated drug research is one of the major reasons for the oversupply of fake and low-quality drugs, and very few products made by Chinese pharma companies hold autonomous intellectual property rights because these companies lack the ability to innovate.
The Chinese government has started to implement GMP (good manufacturing practice), a certification for pharma. Only certified companies will be permitted to fulfill processing commissions, to start their production elsewhere and to apply to produce imitations.
Source: Hua Sheng Overseas Chinese Newspaper
LEHMAN LEE PROVIDES A FULL RANGE OF CHINA ANTI-COUNTERFEITING SERVICES, INVESTIGATIONS, ADMINISTRATIVE AND JUDICIAL ENFORCEMENT
CONTACT US AT mail@chinalaw.cc
Tel: 8610-6532-3861; Fax: 8610-6532-3877
Mainland's Largest Hospital to be built by Taiwan
Nicknamed Taiwan's "plastics king", Mr. Wang Yongqing, the Chairman of the Formosa Petrochemical Co., plans to build the largest hospital on the Chinese mainland.
The hospital will be named Beijing Changgeng Hospital, including a 3,000-bed general hospital, a rehabilitation center and a nursing home.
Taipei Changgeng Hospital will manage the project's investment, and Beijing municipal government will donate the 148-hectare land.
Source: www.southcn.com
Looking to build your web presence in China?
designed_for_china@distilleddesign.com
Web Design | Information Architecture | Hosting | Chinese Language Support | Strategy and Consultation
Drug Prices to Be Regulated
A non-governmental committee, the Pricing Committee of the China Chemical Pharma Industry Association has been finally set up in China to advise on pricing policies, to provide feedback on the implementation of policies and regulate market prices of drugs.
The Pricing Committee is composed of major drug manufacturers in China.
Source: China Medical News
Contact Lehman Lee's Pharma Practice Group
Product Registrations, Anti-Counterfeiting, Import/Export Restrictions, OTC, Mergers & Acquisitions
mail@chinalaw.cc
Tel: 8621-6375-8240; Fax: 8621-6375-8705
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
(formerly known as the L&A Law Firm)
Suite 188, Beijing International Club
21 Jianguomenwai Dajie, Beijing 100020 China
Tel.: (86)(10) 6532-3861
Fax: (86)(10) 6532-3877
mail@chinalaw.cc
http://www.chinalaw.cc/
Contact Our Other Offices:
shanghai@chinalaw.cc - shenyang@chinalaw.cc - tianjin@chinalaw.cc - guangzhou@chinalaw.cc - dalian@chinalaw.cc
The China Lex Pharma Newsletter is intended to be used for news purposes only. It should not be taken as comprehensive legal advice, and Lehman, Lee & Xu will not be held responsible for any such reliance on its contents.
